New Key Statistics Module, Z-Score and F-Score
OTCPK:ALPMY Key Ratios
Market Cap $ M | 17,105.13 |
Enterprise Value $ M | 20,891.99 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.77 |
Price/Sales | 1.73 |
Price/Free Cash Flow | 21.59 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 10,885.00 |
EPS (TTM) $ | -0.008 |
Beneish M-Score | -2.84 |
10-y EBITDA Growth Rate % | 5.50 |
5-y EBITDA Growth Rate % | -3.30 |
y-y EBITDA Growth Rate % | -40.80 |
EV-to-EBIT | 105.47 |
EV-to-EBITDA | 18.67 |
PEG | -- |
Shares Outstanding M | 1,792.99 |
Net Margin (%) | -- |
Operating Margin % | 0.81 |
Pre-tax Margin (%) | 1.40 |
Quick Ratio | 0.71 |
Current Ratio | 0.91 |
ROA % (ttm) | -- |
ROE % (ttm) | -- |
ROIC % (ttm) | -- |
Dividend Yield % | 4.76 |
Altman Z-Score | 1.65 |
ALPMY Number of Guru Trades
ALPMY Volume of Guru Trades
Gurus Latest Trades with OTCPK:ALPMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ALPMY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Astellas Pharma Inc Insider Transactions
No Available Data
News about OTCPK:ALPMY
Total 0- 1